• Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Receives Consensus Rating of "Moderate Buy" from Brokerages

    Source: Buzz FX / 26 Jan 2025 01:25:17   America/Chicago


    Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Receives Consensus Rating of "Moderate Buy" from Brokerages Written by MarketBeat January 26, 2025 Share Link copied to clipboard. Sarepta Therapeutics, Inc. ( NASDAQ:SRPT - Get Free Report ) has ear
    Read more...
Share on,